PT  - JOURNAL ARTICLE
AU  - ILIAS TSOCHANTARIDIS
AU  - GEORGIA-PERSEPHONI VOULGARIDOU
AU  - ALEXANDRA GIATROMANOLAKI
AU  - MICHAEL I. KOUKOURAKIS
AU  - MIHALIS I. PANAYIOTIDIS
AU  - AGLAIA PAPPA
TI  - Profiling of Aldehyde Dehydrogenase Isoforms in <em>In Vitro</em> Formed Tumorspheres
AID  - 10.21873/anticanres.15361
DP  - 2021 Nov 01
TA  - Anticancer Research
PG  - 5481--5488
VI  - 41
IP  - 11
4099  - http://ar.iiarjournals.org/content/41/11/5481.short
4100  - http://ar.iiarjournals.org/content/41/11/5481.full
SO  - Anticancer Res2021 Nov 01; 41
AB  - Background/Aim: Aldehyde dehydrogenases (ALDHs) are considered as markers for normal and cancer stem cells (CSC) and are involved in cell metabolism, proliferation, differentiation, stemness, and retinoic acid (RA) biosynthesis. The aim of the present study was to identify the ALDH isoforms that are associated with the CSC phenotype in non-small cell lung and hepatocellular carcinomas. Materials and Methods: We utilized lung (A549) and hepatocellular (HepG2) cancer cells and generated tumor spheres to isolate the CSC sub-population. Results: The CSC enrichment was confirmed by the up-regulation of various CSC-related genes. Comparative qPCR analysis indicated the up-regulation of several ALDH isoforms in A549 and HepG2 spheres. Interestingly, cyclin D1 and Akt, down-stream targets of the RA signaling pathway, were also shown to be significantly up-regulated in both sphere populations. Conclusion: Specific ALDH isoforms appear to be important mediators for the acquisition of an CSC phenotype and thus, are potential promising targets for CSC-based therapeutic approaches in lung and hepatocellular carcinomas.